Relation of PAI-1 and TPA genes polymorphisms to acute myocardial infarction and its outcomes in Egyptian patients.

about

The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer.

P2860

Q38902224-50A151C9-4DF0-4DC3-B562-C8A7C748B8E3

P2860

Relation of PAI-1 and TPA genes polymorphisms to acute myocardial infarction and its outcomes in Egyptian patients.

Item

http://www.wikidata.org/entity/Q38852956

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Relation of PAI-1 and TPA gene ...... outcomes in Egyptian patients.

@en

type

Item

label

Relation of PAI-1 and TPA gene ...... outcomes in Egyptian patients.

@en

prefLabel

Relation of PAI-1 and TPA gene ...... outcomes in Egyptian patients.

@en

P1476

Relation of PAI-1 and TPA gene ...... outcomes in Egyptian patients.

@en

P2093

Noha A Rezk

http://www.w3.org/2001/XMLSchema#string

Tarek A Abd El-Aziz

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial

Inflammation, atherosclerosis, and coronary artery disease

Plasminogen-activator inhibitor type 1 and coronary artery disease.

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.

Genetic determinants of arterial thrombosis.

Genetics and gene manipulation therapy of premature coronary artery disease.

PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting

Acute myocardial infarction: a failure of timely, spontaneous thrombolysis.

Plasma concentrations of fibrinolytic factors in the subacute phase of myocardial infarction predict recurrent myocardial infarction or sudden cardiac death.

Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients.

P2888

s12013-014-0188-x

P304

227-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12013-014-0188-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1000514874

http://www.w3.org/2001/XMLSchema#string

P698

25113642

http://www.w3.org/2001/XMLSchema#string

Relation of PAI-1 and TPA genes polymorphisms to acute myocardial infarction and its outcomes in Egyptian patients.

about

P2860

P2860

Relation of PAI-1 and TPA genes polymorphisms to acute myocardial infarction and its outcomes in Egyptian patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698